Seek truth from facts, competitive symbiosis
Zhengqing Fengtongning Shines at Hangzhou’s Renowned Nephrology Symposium
Category:
Release time:
2025-12-03
From November 26 to 29, the 2025 Annual Academic Conference of the Nephrology Professional Committee of the Chinese Society for Integrated Traditional Chinese and Western Medicine was grandly held in Hangzhou. Centered on the theme “Equally Emphasizing TCM and Western Medicine, Combining Heritage with Innovation,” the conference brought together leading experts and scholars from across the country in the field of nephrology to discuss cutting-edge developments and breakthroughs in diagnosis and treatment.
As one of the highlights of this major event, Professor Liu Xusheng, Director of the Nephrology Department at Guangdong Provincial Hospital of Traditional Chinese Medicine, specifically highlighted the clinical value of Zhengqing Fengtongning in the treatment of kidney diseases during the plenary keynote session. His expert endorsement sparked an enthusiastic response from the audience, with numerous scholars and experts taking notes, exchanging insights, and learning from his presentation—providing authoritative validation of the product’s efficacy.
During the annual conference, the “Zhengqing Fengtongning 50-Person Forum” was successfully held. Led by Wang Xianping, General Manager of the Marketing Center, the event brought together numerous leading experts in nephrology from top-tier Grade‑III hospitals to discuss… Zhengqing Fengtongning In-depth discussions were held on the application of Zhengqing Fengtongning in the diagnosis and treatment of kidney diseases. At the forum, the product manager systematically presented the clinical outcomes of Zhengqing Fengtongning in the renal field, laying a solid foundation for expert exchange. Professor Jian Guihua from Shanghai Sixth People’s Hospital, drawing on her extensive clinical experience, shared practical insights into the real-world use of Zhengqing Fengtongning, offering valuable clinical guidance, particularly in optimizing dosage and administration. Professor Liu Xusheng also presented his team’s latest research findings, providing an in-depth analysis of the drug’s mechanisms of action in treating kidney disease and offering professional recommendations for managing common adverse reactions. Following thorough deliberation, the attending experts unanimously commended Zhengqing Fengtongning for its remarkable efficacy in improving key outcome measures such as urinary protein and hematuria, thereby establishing a robust academic basis for the product’s further promotion in the renal care setting.
Meanwhile, the company’s meticulously designed booth became one of the event’s major highlights. Attending experts and scholars learned that… The package insert for Zhengqing Fengtongning includes chronic nephritis as an indication. Subsequently, attendees stopped by the booth to carefully study the product’s instructions and inquire about clinical application details related to its indications, as well as key precautions for use. To help experts gain an in-depth understanding of the product, the booth featured a targeted Q&A interactive session, which—through engaging participation—further reinforced awareness of the product’s indications and core value, boosted Zhengqing Fengtongning’s brand visibility in the nephrology field, and successfully established a communication bridge between the product and frontline clinicians.
At this year’s academic conference, Zhengqing Fengtongning showcased its clinical value and academic potential in the treatment of kidney diseases through authoritative recommendations by the conference, expert panel discussions, and interactive exhibits at a dedicated booth, thereby elevating the brand’s promotion in the field of nephrology to a new level. Looking ahead, our group will continue to strengthen its commitment to academic empowerment, leveraging additional clinical research and scholarly exchanges to further unlock the product’s full value, bringing hope to more patients with kidney disease and contributing even more significantly to the high‑quality development of integrated Chinese and Western medicine in the prevention and management of renal disorders.
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Virtual Showroom：
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地